BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Gianluca Masi, Caterina Vivaldi, Lorenzo Fornaro, Sara Lonardi, Piero Buccianti, Aldo Sainato, Lorenzo Marcucci, Angelo Martignetti, Emanuele Damiano Luca Urso, Maura Castagna, Gabriella Fontanini, Francesca Bergamo, Gianna Musettini, Lucio Urbani, Elisa Sensi, Riccardo Balestri, Sabrina Montrone, Francesco Pasqualetti, Chiara Cremolini, Antonello Di Paolo, Vittorina Zagonel, Alfredo Falcone. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trialEuropean Journal of Cancer 2019; 110: 32 doi: 10.1016/j.ejca.2019.01.006
2
Jian Xiao, Zexian Chen, Wenyun Li, Zuli Yang, Yan Huang, Jian Zheng, Yanhong Deng, Lei Wang, Donglin Ren, Junsheng Peng, Ping Lan, Jianping Wang. Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trialCancer Chemotherapy and Pharmacology 2015; 76(1): 21 doi: 10.1007/s00280-015-2763-2
3
Emmanouil Fokas, Maria Antonietta Gambacorta, Claus Rödel, Vincenzo Valentini. Radiation Oncology2018; : 1 doi: 10.1007/978-3-319-52619-5_47-1
4
Sang Woo Park, Jin Soo Kim, Ji Yeon Kim, Kyung Ha Lee. Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomesAnnals of Surgical Treatment and Research 2018; 94(6): 306 doi: 10.4174/astr.2018.94.6.306
5
Rene Warschkow, Sabrina M. Ebinger, Walter Brunner, Bruno M. Schmied, Lukas Marti. Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER AnalysisGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/6058907
6
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, Cynthia Aristei, Carlotta Becherini, Liliana Belgioia, Michela Buglione, Luciana Caravatta, Rolando Maria D’Angelillo, Andrea Riccardo Filippi, Michele Fiore, Domenico Genovesi, Carlo Greco, Lorenzo Livi, Stefano Maria Magrini, Giulia Marvaso, Rosario Mazzola, Icro Meattini, Anna Merlotti, Isabella Palumbo, Stefano Pergolizzi, Sara Ramella, Umberto Ricardi, Elvio Russi, Marco Trovò, Alessandro Sindoni, Vincenzo Valentini, Renzo Corvò. Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacyCritical Reviews in Oncology/Hematology 2019; 134: 87 doi: 10.1016/j.critrevonc.2018.11.005
7
Ben Creavin, Desmond Winter. Coloproctology2017; : 209 doi: 10.1007/978-3-319-55957-5_10
8
Carmine Pinto, Maurizio Di Bisceglie, Francesca Di Fabio, Annamaria Bochicchio, Tiziana Latiano, Stefano Cordio, Gerardo Rosati, Carlo Aschele, Antonella Marino, Francesca Bergamo, Sara Bustreo, Luca Frassineti, Fortunato Ciardiello, Angela Damato, Stefania Giaquinta, Daniela Baldari, Luca Boni. Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low‐Risk, Locally Advanced Rectal Cancer (RaP Study/STAR‐03)The Oncologist 2018; 23(8): 912 doi: 10.1634/theoncologist.2017-0484
9
Laura Melina Fernandez, Guilherme Pagin São Julião, Bruna Borba Vailati, Angelita Habr-Gama, Rodrigo O. Perez. Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME)2019; : 31 doi: 10.1007/978-3-030-11572-2_4
10
Xin Yu, Qiao-xuan Wang, Wei-wei Xiao, Hui Chang, Zhi-fan Zeng, Zhen-hai Lu, Xiao-jun Wu, Gong Chen, Zhi-zhong Pan, De-sen Wan, Pei-rong Ding, Yuan-hong Gao. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II studyCancer Communications 2018; 38(1): 24 doi: 10.1186/s40880-018-0294-z
11
T.A. Greenhalgh, C. Dearman, R.A. Sharma. Combination of Novel Agents with Radiotherapy to Treat Rectal CancerClinical Oncology 2016; 28(2): 116 doi: 10.1016/j.clon.2015.11.002
12
Angelita Habr-Gama, Laura M Fernandez, Rodrigo O Perez. What more do we want from neoadjuvant treatment strategies in rectal cancer?Colorectal Cancer 2015; 4(1): 1 doi: 10.2217/crc.15.5
13
Margaret Lee, Peter Gibbs, Rachel Wong. Multidisciplinary Management of Locally Advanced Rectal Cancer—An Evolving Landscape?Clinical Colorectal Cancer 2015; 14(4): 251 doi: 10.1016/j.clcc.2015.06.002
14
Sven de Mey, Heng Jiang, Hui Wang, Benedikt Engels, Thierry Gevaert, Inès Dufait, Olivier Feron, Joeri Aerts, Valeri Verovski, Mark De Ridder. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancerRadiotherapy and Oncology 2018; 127(3): 361 doi: 10.1016/j.radonc.2018.04.003
15
Vaneja Velenik, Vesna Zadnik, Mirko Omejc, Jan Grosek, Mojca Tuta. Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trialRadiology and Oncology 2020; 0(0) doi: 10.2478/raon-2020-0043
16
Claus Rödel, Ralf Hofheinz, Emmanouil Fokas. Rectal cancer: Neoadjuvant chemoradiotherapyBest Practice & Research Clinical Gastroenterology 2016; 30(4): 629 doi: 10.1016/j.bpg.2016.06.004
17
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, Cynthia Aristei, Carlotta Becherini, Liliana Belgioia, Michela Buglione, Luciana Caravatta, Rolando Maria D’Angelillo, Andrea Riccardo Filippi, Michele Fiore, Domenico Genovesi, Carlo Greco, Lorenzo Livi, Stefano Maria Magrini, Giulia Marvaso, Rosario Mazzola, Icro Meattini, Anna Merlotti, Isabella Palumbo, Stefano Pergolizzi, Sara Ramella, Umberto Ricardi, Elvio Russi, Marco Trovò, Alessandro Sindoni, Vincenzo Valentini, Renzo Corvò. Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicityCritical Reviews in Oncology/Hematology 2019; 134: 104 doi: 10.1016/j.critrevonc.2018.11.006